| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39095d7084ecbb828639c2e7cb45802e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98e72fc1ee2f52f0d07d89efdd041a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b3480902708ea54911c2b1bd2ced368 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d1fd1ea8eb9e8f72fb355ff927691a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f744b4c93c9edf0ff7e8d7c6fd2df7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd5b701ac417174c2f5539af9fef90b3 |
| publicationDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011134898-A1 |
| titleOfInvention |
New combination therapy in treatment of oncological and fibrotic diseases |
| abstract |
The invention relates to new methods for the treatment of oncological and fibrotic disease comprising the combined administration of a cell signalling and/or angiogenesis inhibitor in conjunction with an Aurora kinase inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667718-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014060763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265282-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014009319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8937095-B2 |
| priorityDate |
2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |